핵의학 시장 규모, 점유율, 성장 분석, 진단약, 치료제, 용도, 최종사용자, 지역별, 산업별 예측(2024-2031년)
Nuclear Medicine Market Size, Share, Growth Analysis, By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters), By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드:1619271
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
핵의학 세계 시장 규모는 2022년 91억 달러로 평가되었고, 예측 기간(2024-2031년) 동안 11.8%의 연평균 복합 성장률(CAGR)로 2023년 101억 7,000만 달러에서 2031년 248억 3,000만 달러에 달할 전망입니다.
핵의학 시장은 강력한 제품 파이프라인과 첨단 진단 및 치료 옵션에 대한 접근성을 강화하기 위한 정부 지원 이니셔티브에 힘입어 성장하고 있습니다. 핵의학은 방사성의약품을 이용해 장기의 기능과 구조를 평가하는 여러 분야를 결합하는 분야로 갑상선암과 같은 질병의 조기 발견에 매우 중요합니다. 베탈루틴, 온브르타맙, 이트륨-90 마이크로스피어 등 주요 제품들이 현재 임상시험 중에 있으며, 코로나19 팬데믹으로 인한 어려움에도 불구하고 필수 서비스로 분류되는 원자로는 중요한 의약품을 공급하기 위해 가동을 계속하고 있습니다. 미국 암 협회는 전립선암의 높은 발병률과 최근 전이성 전립선암에 대한 플루빅토의 FDA 승인에서 알 수 있듯이 핵의학의 시급성을 강조하고 있으며, 이는 이 의료 분야의 중요성이 증가하고 있음을 강조하고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter's Five Forces 분석과 영향
경쟁 기업간 경쟁 관계
대체품의 위협
바이어의 교섭력
신규 진출업체의 위협
공급 기업의 교섭력
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
특허 분석
사례 연구
핵의학 시장 규모 : 진단별
시장 개요
SPECT(단일 광자 방출 컴퓨터 단층촬영)
Technetium-99m
Thallium-201
Iodine-123
기타
PET(양전자 방출 단층촬영)
Fluorine-18
Rubidium-82
기타
핵의학 시장 규모 : 치료법별
시장 개요
알파 방사체
Radium-223
Actinium-225
베타 방사체
Iodine-131
Yttrium-90
Lutetium-177
근접 방사선 치료 동위 원소
요오드 125
팔라듐 103
세슘 131
핵의학 시장 규모 : 용도별
시장 개요
종양학
갑상선암
골전이
림프종
심장병학
심근관류 이미징
심실 기능 영상
신경학
뇌 영상
알츠하이머병
기타
소화기 내과
신장학
핵의학 시장 규모 : 최종사용자별
시장 개요
병원
진단센터
연구기관
핵의학 시장 규모 : 지역별
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
시장 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년대비 비교(2021-2023년)
주요 기업 개요
GE Healthcare
Curium Pharma
Novartis
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging S.P.A
Jubilant Life Sciences Ltd
Nordion(Canada), Inc.
Siemens Healthineers
Bayer AG
Eckert & Ziegler
Telix Pharmaceuticals
NorthStar Medical Radioisotopes, LLC
Shine Medical Technologies
Isotopia Molecular Imaging Ltd.
Institute of Isotopes Co., Ltd.
Mediso Ltd.
NTP Radioisotopes SOC Ltd.
ITM Isotopen Technologien Munchen AG
Radiopharm Theranostics
결론과 추천 사항
LSH
영문 목차
영문목차
Global Nuclear Medicine Market size was valued at USD 9.1 billion in 2022 and is poised to grow from USD 10.17 billion in 2023 to USD 24.83 billion by 2031, growing at a CAGR of 11.8% during the forecast period (2024-2031).
The nuclear medicine market is experiencing growth, driven by a strong product pipeline and supportive government initiatives aimed at enhancing accessibility to advanced diagnostic and therapeutic options. This field combines multiple disciplines, utilizing radiopharmaceuticals to assess organ function and structure, crucial for early disease detection such as thyroid cancer. Key products, including betalutin, omburtamab, and yttrium-90 microspheres, are currently in clinical trials. Despite the challenges posed by the COVID-19 pandemic, nuclear reactors, classified as essential services, continued operations to provide critical medicines. The American Cancer Society highlights the urgency of nuclear medicine, as evidenced by the significant incidence of prostate cancer and the recent FDA approval of Pluvicto for metastatic cases, underscoring the growing importance of this medical specialty.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nuclear Medicine Market Segmental Analysis
Global Nuclear Medicine Market is segmented by diagnostics, therapeutics, application, end user and region. Based on diagnostics, the market is segmented into SPECT (single photon emission computed tomography) (technetium-99m, thallium-201, iodine-123, others) and PET (positron emission tomography) (fluorine-18, rubidium-82, others). Based on therapeutics, the market is segmented into alpha emitters (radium-223, actinium-225), beta emitters (iodine-131, yttrium-90, lutetium-177) and brachytherapy isotopes (iodine-125, palladium-103, cesium-131). Based on application, the market is segmented into oncology (thyroid cancer, bone metastasis, lymphoma), cardiology (myocardial perfusion imaging, ventricular function imaging), neurology (brain imaging, alzheimer's disease) and others (gastroenterology, nephrology). Based on end user, the market is segmented into hospitals, diagnostic centers and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Nuclear Medicine Market
The Global Nuclear Medicine market is significantly driven by the increasing incidence and prevalence of cancer and cardiovascular disease (CVD). The World Health Organization reported that cancer was the leading cause of death in 2020, resulting in nearly 10 million fatalities, with projections indicating that 19.3 million new cancer cases will be diagnosed annually by 2025. Furthermore, in 2019, CVD was responsible for 17.9 million deaths, making up 32% of global mortality, and this figure is anticipated to climb to 23.3 million by 2030. The critical role of nuclear medicine in early diagnosis and treatment of these diseases is poised to propel market growth as demand for effective medical interventions rises.
Restraints in the Global Nuclear Medicine Market
The global nuclear medicine market faces several constraints, primarily due to the rising adoption of alternative diagnostic methods for various illnesses. While nuclear medicine techniques like PET scans are commonly used for cancer detection and cardiovascular imaging, technologies such as MRI and CT scans are increasingly favored, especially in developing countries. These alternatives are often more cost-effective, leading to greater utilization as they benefit from supportive reimbursement policies. Consequently, the shift towards these imaging modalities is likely to hinder the growth of the nuclear medicine market in the coming years, as healthcare providers opt for these less expensive diagnostic options.
Market Trends of the Global Nuclear Medicine Market
The global nuclear medicine market is witnessing a significant upward trend, driven by ongoing advancements in nuclear medicine therapies. Companies are increasingly focused on developing innovative therapies that showcase superior clinical efficacy compared to traditional treatment options, particularly in oncology and other high-burden diseases. This surge in demand is bolstered by regulatory endorsements, such as the US FDA's approval for Curium's Phase-III trial of lutetium Lu 177 PSMA I&T, a promising radiopharmaceutical targeting prostate cancer. Additionally, the emergence of new therapeutic agents by various market players is further stimulating growth, reflecting a robust pipeline geared toward addressing diverse medical conditions and enhancing patient care.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Global Nuclear Medicine Market Size by Diagnostics & CAGR (2024-2031)
